✦ LIBER ✦

PDB34 LOWER LONG-TERM COSTS IN GERMAN TYPE-2-DIABETICS STARTING A BASAL SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE COMPARED TO NPH-INSULIN

✍ Scribed by W Kotowa; A Reichelt; M Pfohl; FW Dippel; O Pirk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB38 COST SAVINGS IN TYPE 2 DIABETES WI

✍ A Neilson; S Pscherer; FW Dippel; ES Dietrich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PDB34 A COST-MINIMIZATION ANALYSIS FOR T

✍ H Dong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Basal Supported Oral Therapy with Insuli

✍ Martin Pfohl; Franz-Werner Dippel; Karel Kostev; Sabine Fuchs; Wioletta Kotowa 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 441 KB

PDB10 DIFFERENT PERSISTENCE WITH A BASAL

✍ A Reichelt; M Pfohl; FW Dippel; O Pirk; W Kotowa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PDB35 LOWER TREATMENT COSTS WITH INSULIN

✍ R Bierwirth; T Kohlmann; FW Dippel; W Landgraf; R Holle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PDB16 INSULIN GLARGINE IS ASSOCIATED WIT

✍ T Siegmund; FW Dippel; K Kostev; S Lauterbach; S Fuchs; W Kotowa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB